Subsequently, we evaluated the mRNA expression of SLC41A3 in twenty-two cancer cell lines from the CCLE database, and the results revealed that the expression levels of SLC41A3 varied significantly among cancer cell lines [Kruskal-Wallis test P<0.001 (Figure 1B) with ANONA test P<0.001 (Figure S1B)]. The gene discussed is SLC41A3; the disease is cancer.